Evidence map›Paper›PMID 21350190›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2011

Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.

R Scott Rector, Grace M Uptergrove, E Matthew Morris, Sarah J Borengasser, M Harold Laughlin, Frank W Booth, John P Thyfault, Jamal A Ibdah

Open access · greenAbstract readComparative Study
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Comprehensive lifestyle interventionWorld journal of gastroenterology · 2019
    Trial
  3. Trial
  4. Simvastatin impairs exercise training adaptations.Journal of the American College of Cardiology · 2013 · on this map
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Targeting ketone body metabolism to treat fatty liver disease.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

R Scott RectorDivision of Gastroenterology and Hepatology, Univ. of Missouri, Columbia, MO 65212, USA.
Grace M Uptergrove
E Matthew Morris
Sarah J Borengasser
M Harold Laughlin
Frank W Booth
John P Thyfault
Jamal A Ibdah
Harry S. Truman Memorial Veterans' Hospital · USInstitute of Biomedical Science · GBUniversity of Missouri · US

Funding

TRAINING: MUSCLE BLOOD FLOW &CAPILLARY DYNAMICSR01HL036088 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI LAUGHLIN, M HAROLD · 1985 to 2013
$4.0M
Maternal Liver Disease and Fatty Acid Oxidation DefectsR01DK056345 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI IBDAH, JAMAL A · 2001 to 2005
$1.5M
Exercise, mitochondrial function, and fatty acid oxidation in fatty liver diseaseF32DK083182 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · PI RECTOR, RANDY SCOTT · 2008 to 2009
$88k
NHLBI NIH HHS HL-36088NHLBI NIH HHS R01 HL036088NIDDK NIH HHS DK-56345NIDDK NIH HHS F32 DK083182NIDDK NIH HHS F32 DK-83182NIDDK NIH HHS R01 DK056345
6 · The paper itself

Abstract

The maintenance of normal body weight either through dietary modification or being habitually more physically active is associated with reduced incidence of nonalcoholic fatty liver disease (NAFLD). However, the means by which weight gain is prevented and potential mechanisms activated remain largely unstudied. Here, we sought to determine the effects of obesity prevention by daily exercise vs. caloric restriction on NAFLD in the hyperphagic, Otsuka Long-Evans Tokushima Fatty (OLETF) rat. At 4 wk of age, male OLETF rats (n = 7-8/group) were randomized to groups of ad libitum fed, sedentary (OLETF-SED), voluntary wheel running exercise (OLETF-EX), or caloric restriction (OLETF-CR; 70% of SED) until 40 wk of age. Nonhyperphagic, control strain Long-Evans Tokushima Otsuka (LETO) rats were kept in sedentary cage conditions for the duration of the study (LETO-SED). Both daily exercise and caloric restriction prevented obesity and the development of type 2 diabetes observed in the OLETF-SED rats, with glucose tolerance during a glucose tolerance test improved to a greater extent in the OLETF-EX animals (30-50% lower glucose and insulin areas under the curve, P < 0.05). Both daily exercise and caloric restriction also prevented excess hepatic triglyceride and diacylglycerol accumulation (P < 0.001), hepatocyte ballooning and nuclear displacement, and the increased perivenular fibrosis and collagen deposition that occurred in the obese OLETF-SED animals. However, despite similar hepatic phenotypes, OLETF-EX rats also exhibited increased hepatic mitochondrial fatty acid oxidation, enhanced oxidative enzyme function and protein content, and further suppression of hepatic de novo lipogenesis proteins compared with OLETF-CR. Prevention of obesity by either daily exercise or caloric restriction attenuates NAFLD development in OLETF rats. However, daily exercise may offer additional health benefits on glucose homeostasis and hepatic mitochondrial function compared with restricted diet alone.

Indexed as

Caloric RestrictionAbsorptiometry, PhotonAdipose TissueAnimalsAntioxidantsBlotting, WesternFatty AcidsFatty LiverGlucoseGlucose Tolerance TestInsulinLipogenesisLiverMaleMitochondria, LiverObesityAntioxidantsFatty AcidsGlucoseInsulin

Identifiers

PMID21350190
PMCPMC3094141
OpenAlexW1996271130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.